{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Coronary+Insufficiency", "query": { "condition": "Chronic Coronary Insufficiency" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 154, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Coronary+Insufficiency&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T09:05:12.440Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00700947", "title": "Using Beta Blockers to Treat Mitral Regurgitation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Heart Disease", "Mitral Regurgitation", "Heart Valve Disease", "Mitral Valve Insufficiency" ], "interventions": [ { "name": "Beta-blocker therapy (TOPROL-XL® )", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2007-10", "completion_date": "2009-09", "has_results": false, "last_update_posted_date": "2018-08-14", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00700947" }, { "nct_id": "NCT00328809", "title": "Spironolactone Safety in Dialysis Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "End Stage Renal Disease", "Congestive Heart Failure" ], "interventions": [ { "name": "spironolactone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "State University of New York - Upstate Medical University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2013-06-30", "completion_date": "2019-09-24", "has_results": false, "last_update_posted_date": "2020-10-22", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 1, "location_summary": "Syracuse, New York", "locations": [ { "city": "Syracuse", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00328809" }, { "nct_id": "NCT02966028", "title": "Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cardiovascular Diseases", "Cardiovascular Abnormalities", "Calcifications, Vascular", "Endstage Renal Disease", "ESRD", "Coronary Artery Calcification" ], "interventions": [ { "name": "SNF472", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanifit Therapeutics S. A.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 274, "start_date": "2016-11", "completion_date": "2019-09", "has_results": true, "last_update_posted_date": "2021-04-15", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 46, "location_summary": "Bakersfield, California • Chula Vista, California • Escondido, California + 42 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "La Palma", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02966028" }, { "nct_id": "NCT03993886", "title": "A Study AnalyZing a NovEl Wearable SeNsor for Remote PatIent Health Monitoring", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure", "Chronic Kidney Diseases" ], "interventions": [ { "name": "CorBand", "type": "DEVICE" }, { "name": "Activity Monitor", "type": "OTHER" }, { "name": "Bioimpedance spectrometer", "type": "OTHER" }, { "name": "ECG", "type": "OTHER" }, { "name": "respiratory rate sensor", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "ReThink Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2019-01-17", "completion_date": "2020-07-14", "has_results": false, "last_update_posted_date": "2020-07-17", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 2, "location_summary": "San Francisco, California • San Jose, California", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03993886" }, { "nct_id": "NCT03888066", "title": "Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperkalemia" ], "interventions": [ { "name": "Patiromer", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vifor Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1195, "start_date": "2019-04-24", "completion_date": "2021-09-02", "has_results": true, "last_update_posted_date": "2023-02-24", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 133, "location_summary": "Alexander City, Alabama • Huntsville, Alabama • Phoenix, Arizona + 110 more", "locations": [ { "city": "Alexander City", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03888066" }, { "nct_id": "NCT01012414", "title": "Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Artery Disease", "Chronic Kidney Disease", "Hypovitaminosis D", "Secondary Hyperparathyroidism" ], "interventions": [ { "name": "paricalcitol", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2010-01", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2014-05-20", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01012414" }, { "nct_id": "NCT00325611", "title": "Multidisciplinary Inpatient Palliative Care Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cerebrovascular Accident", "Cancer", "Coronary Arteriosclerosis", "Heart Failure, Congestive", "Diabetes Mellitus", "Acquired Immunodeficiency Syndrome", "Failure to Thrive", "Pulmonary Disease, Chronic Obstructive", "Dementia", "Kidney Failure, Chronic", "Pneumonia", "Liver Failure", "Renal Failure", "Respiratory Failure", "Stroke" ], "interventions": [ { "name": "Multidisciplinary palliative care team met with patient", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 550, "start_date": "2002-04", "completion_date": "2004-07", "has_results": false, "last_update_posted_date": "2006-05-15", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00325611" }, { "nct_id": "NCT04067635", "title": "Primary Mitral Regurgitation Repair", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mitral Valve Insufficiency", "Mitral Valve Prolapse", "Chronic Mitral Disease", "Mitral Regurgitation", "Mitral Valve Disease", "Degenerative Mitral Valve Disease", "Myxomatous Mitral Valve Degeneration", "Ventricular Remodeling" ], "interventions": [], "intervention_types": [], "sponsor": "Eric Y. Yang, MD PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 116, "start_date": "2018-05-25", "completion_date": "2021-06", "has_results": false, "last_update_posted_date": "2019-08-28", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04067635" }, { "nct_id": "NCT07083557", "title": "Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obesity and Obesity-related Medical Conditions", "Diabetes", "Atherosclerotic Disease", "Heart Failure", "MASH", "Sarcopenia", "Osteoporosis", "Hyperparathyroidism", "Hypoparathyroidism", "Ischemic Heart Disease", "Cystic Fibrosis (CF)", "Chronic Kidney Disease(CKD)", "Osteopenia", "Cachexia" ], "interventions": [ { "name": "Endothelial cell collection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Bettina Mittendorfer", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 100, "start_date": "2027-01-01", "completion_date": "2030-07-01", "has_results": false, "last_update_posted_date": "2026-05-07", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07083557" }, { "nct_id": "NCT00863707", "title": "A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Kidney Diseases", "Coronary Artery Disease" ], "interventions": [ { "name": "Regadenoson", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 511, "start_date": "2009-04", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2012-05-18", "last_synced_at": "2026-05-22T09:05:12.440Z", "location_count": 41, "location_summary": "Anniston, Alabama • Little Rock, Arkansas • Bell Gardens, California + 36 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bell Gardens", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00863707" } ] }